Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EPR Properties (EPR) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

EPR PropertiesTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

EPR Properties vs Neurocrine Biosciences Inc — how do they compare? EPR Properties trades at $59.8 (market cap $4.58B), while Neurocrine Biosciences Inc trades at $151.61 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.6× EPR Properties's market cap, and EPR Properties pays a 6.22% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

EPRNBIX
Market Cap
$4.58B$16.46B
Sector
Real EstateHealth
52-Week High
$64.32$185.50
52-Week Low
$48.71$123.10
Enterprise Value
$8.09B$16.48B
Dividend Yield
6.22%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About EPR Properties

EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.

Read more on EPR

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX